O46.091
Antepartum hemorrhage with other coagulation defect, first trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Antepartum hemorrhage refers to bleeding from the genital tract during pregnancy, specifically after the 20th week and before the onset of labor. When this bleeding occurs in the first trimester alongside a coagulation defect, it indicates a complex condition that affects blood clotting processes. The ICD-10 code O46.091 categorizes this particular type of bleeding and clotting disorder, emphasizing its significance in maternal health. Recognizing the symptoms, causes, and management options associated with this condition is crucial for ensuring maternal and fetal well-being.
Causes & Symptoms
Clinical Causes: Underlying coagulation disorders such as platelet dysfunction or clotting factor deficiencies. Placental abnormalities, including placental abruption or previa, which may be associated with clotting issues. Inherited bleeding disorders, such as hemophilia or von Willebrand disease. Use of anticoagulant medications during pregnancy. Infections that impact blood clotting mechanisms. Other medical conditions that interfere with normal blood clotting processes.
Key Symptoms: Vaginal bleeding that varies in amount, from spotting to heavy bleeding. Abdominal or pelvic pain or tenderness. Signs of anemia, such as weakness or dizziness, especially with significant blood loss. Possible changes in fetal movement or activity patterns. Occasional clots or tissue passing through the vagina. In severe cases, symptoms of shock like rapid heartbeat and low blood pressure.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Key steps include: - Medical history review, including prior bleeding episodes or coagulation disorders. - Physical examination focusing on abdominal and vaginal findings. - Blood tests to assess hemoglobin levels, platelet counts, and coagulation profile (including PT, aPTT, and bleeding time). - Ultrasound imaging to evaluate placental status and fetal health. - Specific assays to identify inherited or acquired clotting disorders if indicated. Early diagnosis is essential to guide appropriate treatment and management strategies.
Treatment Protocols: Management focuses on controlling bleeding, correcting coagulation abnormalities, and ensuring the health of both mother and fetus. Typical approaches include: - Hospitalization for monitoring and supportive care. - Blood transfusions if blood loss is significant. - Administration of clotting factor concentrates or replacement therapies for identified defects. - Use of medications to promote blood clotting or reduce bleeding. - Careful monitoring of fetal well-being through ultrasound and fetal heart rate assessments. - Avoidance of activities or medications that could exacerbate bleeding. - Planning for delivery based on the severity of bleeding and gestational age. In some cases, early delivery may be necessary if maternal or fetal health is at risk, always under close medical supervision.
Clinical Advice & FAQs
Billing Guidance
Is O46.091 a billable ICD-10 code?
Yes, O46.091 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O46.091?
Clinical documentation must specify the nature of Antepartum hemorrhage with other coagulation defect, first trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
